CENTER VALLEY, Pa. & SIGNY, Switzerland--(BUSINESS WIRE)--Shift4 Payments, Inc. (“Shift4”) (NYSE: FOUR), the leader in integrated payments and commerce technology, and Global Blue Group Holding AG (“Global Blue”) (NYSE: GB), the leading specialty payments and technology platform enabling tax-free shopping, dynamic currency conversion, and payments solutions to the world's largest retail brands, today announced the successful completion of the squeeze-out merger under Swiss law pursuant to which.

Meta Platforms stock has surged this year and a new piece of hardware could keep the momentum going.

Google and Kairos Power will deploy an advanced nuclear reactor to help power the tech company's data centers on the Tennessee Valley Authority grid. The Hermes 2 reactor developed by Kairos will dispatch 50 megawatts of electricity, enough to power about 36,000 homes.

Specialty Coffee Chain Sees Potential to Leverage Blockchain Innovation Across Treasury Management, Payments, and Customer Engagement while Advancing Aggressive Global Expansion Plans BREA, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (Nasdaq: REBN), a leader in the specialty coffee market, today announced it has initiated a strategic review to assess the potential use of regulated digital asset strategies as part of its broader treasury management framework.

NEW YORK and TOKYO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Go IPO client, rYojbaba Co., Ltd. (“rYojbaba”), has successfully commenced trading under the symbol “RYOJ” on the Nasdaq Capital Market. HeartCore was compensated through an aggregate $500,000 in initial fees and warrants to acquire 3% of rYojbaba's common stock, on a fully diluted basis, which total up to approximately $1.35 million as of August 14, 2025.

Avalo Therapeutics' value mostly hinges on AVTX-009. This is an IL-1β mAb in a Phase 2 LOTUS trial for hidradenitis suppurativa. This Phase 2 trial should give us topline results by mid-2026, which I consider its most significant near-term value driver at this point. AVTX-009 also seems to have higher affinity and half-life versus Lutikizumab, which could allow for fewer doses and stronger efficacy.

ATLANTA & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange (NYSE: ICE), a leading global provider of technology and data, today announced record trading volume in the first half of 2025 for corporate bond and municipal bond trading on the ICE Bonds' electronic execution platforms. Trading on ICE Bonds reached record notional volume of $120 billion for corporate bonds in the first half of 2025, up 20% from the first half of 2024. Municipal bond trading reached record notional volume of $109.

COLORADO SPRINGS, Colo., Aug. 18, 2025 /PRNewswire/ -- Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) announced today that its Rocky Gap Casino, Resort & Golf ("Rocky Gap") received multiple first-place awards in Casino Player Magazine's Best of Gaming Awards 2025: Maryland.

SALINAS, Calif.--(BUSINESS WIRE)---- $ACHR #Archer--Archer Aviation (NYSE: ACHR) today announced that its Midnight aircraft successfully completed its longest piloted flight to date, flying approximately 55 miles in 31 minutes at speeds exceeding 126 mph. The flight took place at Archer's flight test facility in Salinas, California, in front of United Airlines' Chief Financial Officer, Mike Leskinen, who led United Airlines' early investment in Archer. Test flights in the preceding week reached speeds of nearly.

SINGAPORE--(BUSINESS WIRE)--Vantage Corp (NYSE American: VNTG) (“Vantage” or the “Company”), a shipbroking company providing comprehensive services including brokerage, consultancy, and operational support in the tanker market, announced that its wholly-owned subsidiary, Vantage (BVI) Corporation, has signed two additional non-binding Letters of Intent (LOI) to acquire a Hong Kong and Mainland China-based firm specializing in shipbroking and maritime services. Following the recently announced p.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Alto Neuroscience, Inc. ("Alto Neuroscience" or "the Company") (NYSE: ANRO) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering ("IPO") conducted on or about February 2, 2024 and/or between February 2, 2024 and October 22, 2024, both dates inclusive (the "Class Period"), are encouraged to contact the firm before September 19, 2025.

Apeiro will expand Ondas' capabilities into ground robotics and add fiber optic components for radio-independent UAV and UGV communications Through mature platforms, strategic customer relationships, and an expected $12 million in 2025 revenues, Apeiro will accelerate operating scale and commercial reach Acquisition demonstrates Ondas' commitment to leveraging its global operating platform to deliver a portfolio of advanced, AI-enabled capabilities to critical defense and security customers Transaction is expected to close in the third quarter of 2025 BOSTON, MA / ACCESS Newswire / August 18, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of private industrial …

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, reports that its broad-spectrum antiviral drug NV-387 could help reduce resurgence of metastatic cancer caused by awakening of "sleeping" cancer cells due to viral infections. NV-387 has successfully completed a Phase I clinical trial and is being advanced into Phase II clinical trials.

ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the appointment of its new Chief Financial Officer as the Company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization.

Conference Call to Discuss Previously Announced Transaction and Workhorse's Second Quarter 2025 Financial Results Shareholders Can Submit Questions by Emailing [email protected] CINCINNATI and FOSTER CITY, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or the “Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, and Motiv Electric Trucks (“Motiv”), a leading manufacturer of medium-duty electric trucks and buses, remind shareholders that the companies will hold a conference call tomorrow morning, Tuesday, August 19, at 10:00 a.m.

SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, 2025.

VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI), a leading near-commercial lithium company, is announcing the appointment of Michael Lutgring as General Counsel, effective August 18, 2025.

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments

HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition and Method of Controlling Infectious Diseases with Functional Fragrances,” developed within IBO's 3F™ technology platform.

SUNRISE, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT), a leading distributor and fulfillment partner of entertainment and pop culture collectibles, is thrilled to announce the release of three new Collector-Edition Handmade by Robots™ vinyl figures featuring the iconic Leatherface from the legendary horror film, The Texas Chain Saw Massacre. This release coincides with Texas Chain Saw Day, a nationwide theatrical celebration honoring the film's enduring legacy and influence.